Several of these genes, such as CMTR1 and GMPR, have known roles in RNA modification and purine metabolism, respectively, processes that are commonly dysregulated in cancer, particularly in aggressive subtypes like GBM. This evidence concerns the gene CMTR1 and glioblastoma.